Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.WuXi PharmaTech names two new board members
Mr Hen is a managing director at Warburg Pincus, a private equity firm. He focuses on investments in biotechnology and pharmaceuticals, including pharmaceutical outsourcing. Dr Zhao, one of
Mr Hen is a managing director at Warburg Pincus, a private equity firm. He focuses on investments in biotechnology and pharmaceuticals, including pharmaceutical outsourcing. Dr Zhao, one of
The compound proved to be least toxic and extremely effective in controlling the growth of SF295 human glioblastoma xenografts, the company said. According to PhytoMedical, in all cases
According to the company, this measure is intended to maintain the company’s emphasis on its active preclinical and clinical programs, while conserving the company resources. The company is
For the fourth quarter of 2008, total revenues were $4.34 million, compared to $1.78 million in the same quarter of 2007. For 2008, total revenues were $14.97 million,
SNS-01 is a nano-encapsulated combination therapy of Factor5A and an siRNA against Factor 5A. These studies, undertaken to determine the efficacy, maximum tolerated dose and the feasibility of
This agreement gives Rhei the first option to license the exclusive rights for Skinvisible’s dermatology products for the territory of China, Hong Kong and Taiwan. Specifically the agreement
For the fourth quarter of 2008, total revenue was $811.3 million, up 2.8%, on robust sales to clinical diagnostics customers, partially offset by a decline in Life Sciences
This approval includes 24 EU member countries that take part in the Medicines and Healthcare products Regulatory Agency (MHRA) ‘mutual recognition procedure’. A similar application for the expanded
“The election of Peter Bambic as the new President and CEO of Adaltis Inc. comes at a very exciting time in the history of the Company, as we
For the fourth quarter of fiscal 2008, revenues were $37.8 million, compared to $40.4 million in the same quarter of fiscal 2007. For the full fiscal year ended